BioCentury
ARTICLE | Product Development

Collaborating to clobber COVID-19

NIH and FNIH are leading a public-private parternship to defeat COVID-19

April 18, 2020 3:00 AM UTC
Updated on Apr 21, 2020 at 10:15 PM UTC

An overlapping set of collaborations is focusing the combined intellectual, logistic and economic resources of the life sciences industry, government, academia and non-profits against SARS-Cov2, the virus that causes COVID-19.

The latest and broadest collaboration was disclosed Friday when NIH and the Foundation for the NIH (FNIH) announced Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership to coordinate and accelerate the development of medical countermeasures. ...



Access The Full Article